Literature DB >> 18376401

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Tiziana Di Pucchio1, Bithi Chatterjee, Anna Smed-Sörensen, Sandra Clayton, Adam Palazzo, Monica Montes, Yaming Xue, Ira Mellman, Jacques Banchereau, John E Connolly.   

Abstract

Although plasmacytoid dendritic cells (pDCs) respond to virus replication in a nonspecific way by producing large amounts of type I interferon, a rapid, direct function for pDCs in activating antiviral lymphocytes is less apparent. Here we show that pDCs were able to rapidly initiate antigen-specific antiviral CD8+ T cell responses. After being exposed to virus, pDCs efficiently and rapidly internalized exogenous viral antigens and then presented those antigens on major histocompatibility complex (MHC) class I to CD8+ T cells. Processing of exogenous antigen occurred in endocytic organelles and did not require transit of antigen to the cytosol. Intracellular stores of MHC class I partially localized together with the transferrin receptor and internalized transferrin in endosomes, which suggested that such recycling endosomes are sites for loading peptide onto MHC class I or for peptide transit. Our data demonstrate that pDCs use 'ready-made' stores of MHC class I to rapidly present exogenous antigen to CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376401      PMCID: PMC2695657          DOI: 10.1038/ni.1602

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  41 in total

1.  Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.

Authors:  Gregory Lizée; Genc Basha; Jacqueline Tiong; Jean-Pierre Julien; Meimei Tian; Kaan E Biron; Wilfred A Jefferies
Journal:  Nat Immunol       Date:  2003-10-19       Impact factor: 25.606

2.  Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.

Authors:  Andrea A Itano; Stephen J McSorley; R Lee Reinhardt; Benjamin D Ehst; Elizabeth Ingulli; Alexander Y Rudensky; Marc K Jenkins
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

3.  Phagosomes are competent organelles for antigen cross-presentation.

Authors:  Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

4.  Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo.

Authors:  Lianjun Shen; Luis J Sigal; Marianne Boes; Kenneth L Rock
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

Review 5.  The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.

Authors:  Colin Watts
Journal:  Nat Immunol       Date:  2004-07       Impact factor: 25.606

Review 6.  MHC class II compartment subtypes: structure and function.

Authors:  Lawrence J Stern; Ilaria Potolicchio; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2005-12-06       Impact factor: 7.486

7.  Developmental regulation of MHC class II transport in mouse dendritic cells.

Authors:  P Pierre; S J Turley; E Gatti; M Hull; J Meltzer; A Mirza; K Inaba; R M Steinman; I Mellman
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

8.  In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

Authors:  A Y Huang; A T Bruce; D M Pardoll; H I Levitsky
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

9.  Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.

Authors:  E Ashley Moseman; Xueqing Liang; Amanda J Dawson; Angela Panoskaltsis-Mortari; Arthur M Krieg; Yong-Jun Liu; Bruce R Blazar; Wei Chen
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

10.  The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.

Authors:  G Grouard; M C Rissoan; L Filgueira; I Durand; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  138 in total

1.  Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Authors:  Eynav Klechevsky; Anne-Laure Flamar; Yanying Cao; Jean-Philippe Blanck; Maochang Liu; Amy O'Bar; Olivier Agouna-Deciat; Peter Klucar; Luann Thompson-Snipes; Sandra Zurawski; Yoram Reiter; A Karolina Palucka; Gerard Zurawski; Jacques Banchereau
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

Review 2.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

Review 3.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 5.  Dynamics of dendritic cell-T cell interactions: a role in T cell outcome.

Authors:  Stéphanie Hugues
Journal:  Semin Immunopathol       Date:  2010-07-06       Impact factor: 9.623

Review 6.  Molecular characterization of human plasmacytoid dendritic cells.

Authors:  Wei Cao
Journal:  J Clin Immunol       Date:  2009-03-06       Impact factor: 8.317

Review 7.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

8.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

Review 9.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 10.  The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions.

Authors:  Julien J Karrich; Loes C M Jachimowski; Christel H Uittenbogaart; Bianca Blom
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.